These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 766891)
1. Proceedings: The effect of Bacille Calmette-Guérin (BCG) and Corynebacterium parvum on the development of spontaneous mouse mammary carcinoma. Simpson JS; Clark AW Br J Surg; 1976 Feb; 63(2):152-3. PubMed ID: 766891 [No Abstract] [Full Text] [Related]
2. The effect of intramural injection of immunotherapeutic agents on bladder histology and systemic humoral response. Albert NE; Sparks FC; Lytton B Invest Urol; 1978 Sep; 16(2):134-9. PubMed ID: 361626 [TBL] [Abstract][Full Text] [Related]
3. Corynebacterium parvum- and Mycobacterium bovis Bacillus Calmette and Guerin-induced granuloma formation in mice lacking CD4 and CD8. Senaldi G; Shaklee CL; Mak TW; Ulich TR Cell Immunol; 1999 May; 193(2):155-61. PubMed ID: 10222057 [TBL] [Abstract][Full Text] [Related]
4. Mammary tumor growth inhibition in C3H/He mice by long-term Bacillus Calmette-Guérin immunoprophylaxis versus enhancement by primary Bacillus Calmette-Guérin therapy. Vaage J Cancer Res; 1983 Dec; 43(12 Pt 1):5778-82. PubMed ID: 6357431 [TBL] [Abstract][Full Text] [Related]
5. Effect of BCG and Corynebacterium Parvum on allograft survival after rabbit antimouse lymphocyte serum and donor bone marrow. Clark AW; Monaco AP Surg Forum; 1973; 24():340-3. PubMed ID: 4618660 [No Abstract] [Full Text] [Related]
7. Comparative antitumor effects of Corynebacterium parvum, Bordetella pertussis, Bacillus Calmette-Guérin, and levamisole alone or in combination with cyclophosphamide in the CaD2 murine mammary adenocarcinoma system. Purnell DM; Bartlett GL; Kreider JW; Biro TG; Kontra J Cancer Res; 1979 Dec; 39(12):4838-42. PubMed ID: 498111 [TBL] [Abstract][Full Text] [Related]
8. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma. Gutterman JU; Mavligit GM; Reed R; Burgess MA; Gottlieb J; Hersh EM Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970 [TBL] [Abstract][Full Text] [Related]
9. Stimulation of the non-specific resistance by Corynebacterium parvum and Bacillus calmette Guérin. Ruitenberg EJ; Steerenberg PA Tijdschr Diergeneeskd; 1976 Jul; 101(14):775-8. PubMed ID: 821172 [TBL] [Abstract][Full Text] [Related]
10. Systemic antitumor activity of Bacillus Calmette Guerin and purified protein derivatives against tumors in mice having tuberculin allergy. Abe S; Saito M; Yamazaki M; Mizuno D; Tsumita T Jpn J Exp Med; 1978 Oct; 48(5):455-7. PubMed ID: 372638 [No Abstract] [Full Text] [Related]
11. [Treatment of solid tumours by intratumoral injection of immunostimulants]. Salomon JC; Lynch N Ann Immunol (Paris); 1977; 128(1-2):125-7. PubMed ID: 322574 [TBL] [Abstract][Full Text] [Related]
12. Effect of Myobacterium bovis (strain Bacillus Calmette-Guérin) on macrophage production by the bone marrow of tumor-bearing mice. Fisher B; Taylor S; Levine M; Saffer E; Fisher ER Cancer Res; 1974 Jul; 34(7):1668-70. PubMed ID: 4599359 [No Abstract] [Full Text] [Related]
13. The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in syngeneic tumor-bearing mice. Wolmark N; Fisher B Cancer Res; 1974 Nov; 34(11):2869-72. PubMed ID: 4419513 [No Abstract] [Full Text] [Related]
14. Interferon production by Corynebacterium parvum and BCG-activated murine spleen macrophages. Neumann C; Macher E; Sorg C Immunobiology; 1980 Apr; 157(1):12-23. PubMed ID: 6162779 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the inhibition of tumor growth following local or systemic administration of Corynebacterium parvum or other immunostimulating agents with or without cyclophosphamide. Fisher B; Gebhardt M; Linta J; Saffer E Cancer Res; 1978 Sep; 38(9):2679-87. PubMed ID: 679170 [No Abstract] [Full Text] [Related]
16. Conditions for effective Bacillus Calmette-Guérin immunotherapy of postsurgical metastases of 13762A rat mammary adenocarcinoma. Kreider JW; Bartlett GL; Boyer CM; Purnell DM Cancer Res; 1979 Mar; 39(3):987-92. PubMed ID: 427785 [TBL] [Abstract][Full Text] [Related]
17. Corynebacterium parvum- and Mycobacterium bovis bacillus Calmette-Guerin-induced granuloma formation is inhibited in TNF receptor I (TNF-RI) knockout mice and by treatment with soluble TNF-RI. Senaldi G; Yin S; Shaklee CL; Piguet PF; Mak TW; Ulich TR J Immunol; 1996 Dec; 157(11):5022-6. PubMed ID: 8943410 [TBL] [Abstract][Full Text] [Related]
18. Effect of glucan and other adjuvants on the clearance of radiolabeled tumor cells from mouse lungs. Proctor JW; Stiteler RD; Yamamura Y; Mansell PW; Winters R Cancer Treat Rep; 1978 Nov; 62(11):1873-80. PubMed ID: 728905 [TBL] [Abstract][Full Text] [Related]
19. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection. Mollenkopf HJ; Kursar M; Kaufmann SH J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936 [TBL] [Abstract][Full Text] [Related]
20. Effect of anti-thymocyte serum, anti-macrophage serum, and latex particles on the therapeutic efficacy of BCG or Corynebacterium liquefaciens (Propionibacterium acnes C7) in syngeneic mice. Tanaka T; Nakagawa H; Kato A; Yoshimura M; Fujita H; Kimura K Gan; 1977 Feb; 68(1):45-52. PubMed ID: 324858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]